Cargando…
Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients()()
INTRODUCTION: The Montreal Cognitive Assessment (MoCA), an instrument widely used for cognitive screening in Parkinson's disease (PD), is validated in Hebrew and English. However, it remains unknown whether the scores are comparable. METHODS: The MoCA was analyzed in 483 Ashkenazi Jewish PD pat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174235/ https://www.ncbi.nlm.nih.gov/pubmed/34095813 http://dx.doi.org/10.1016/j.prdoa.2020.100042 |
_version_ | 1783702864207544320 |
---|---|
author | Xu, Yaqian Mirelman, Anat Saunders-Pullman, Rachel Mejia-Santana, Helen Caccappolo, Elise Raymond, Deborah Giladi, Nir Bressman, Susan Marder, Karen Alcalay, Roy N. |
author_facet | Xu, Yaqian Mirelman, Anat Saunders-Pullman, Rachel Mejia-Santana, Helen Caccappolo, Elise Raymond, Deborah Giladi, Nir Bressman, Susan Marder, Karen Alcalay, Roy N. |
author_sort | Xu, Yaqian |
collection | PubMed |
description | INTRODUCTION: The Montreal Cognitive Assessment (MoCA), an instrument widely used for cognitive screening in Parkinson's disease (PD), is validated in Hebrew and English. However, it remains unknown whether the scores are comparable. METHODS: The MoCA was analyzed in 483 Ashkenazi Jewish PD patients in Tel-Aviv and New York who had MoCA ≥21. Each section of the MoCA was compared between English and Hebrew. Linear regression models were used to test the association between MoCA performance and language. RESULTS: Total MoCA scores were lower in Hebrew than in English (25.4 versus 26.1; P = 0.007), even after adjustment for age, sex, PD duration, genotype, levodopa equivalent dose, the Unified Parkinson's Disease Rating Scale (UPDRS-III), and Geriatric Depression Scale score in a linear model (P < 0.001). However, when language sections were removed from the total, scores were similar between the languages (Hebrew 23.7 versus English 23.4, P = 0.111). CONCLUSION: The language section of the MoCA may be more difficult in Hebrew. The comparability of MoCA in different languages requires further evaluation. |
format | Online Article Text |
id | pubmed-8174235 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-81742352021-06-03 Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients()() Xu, Yaqian Mirelman, Anat Saunders-Pullman, Rachel Mejia-Santana, Helen Caccappolo, Elise Raymond, Deborah Giladi, Nir Bressman, Susan Marder, Karen Alcalay, Roy N. Clin Park Relat Disord Short Communication INTRODUCTION: The Montreal Cognitive Assessment (MoCA), an instrument widely used for cognitive screening in Parkinson's disease (PD), is validated in Hebrew and English. However, it remains unknown whether the scores are comparable. METHODS: The MoCA was analyzed in 483 Ashkenazi Jewish PD patients in Tel-Aviv and New York who had MoCA ≥21. Each section of the MoCA was compared between English and Hebrew. Linear regression models were used to test the association between MoCA performance and language. RESULTS: Total MoCA scores were lower in Hebrew than in English (25.4 versus 26.1; P = 0.007), even after adjustment for age, sex, PD duration, genotype, levodopa equivalent dose, the Unified Parkinson's Disease Rating Scale (UPDRS-III), and Geriatric Depression Scale score in a linear model (P < 0.001). However, when language sections were removed from the total, scores were similar between the languages (Hebrew 23.7 versus English 23.4, P = 0.111). CONCLUSION: The language section of the MoCA may be more difficult in Hebrew. The comparability of MoCA in different languages requires further evaluation. Elsevier 2020-02-11 /pmc/articles/PMC8174235/ /pubmed/34095813 http://dx.doi.org/10.1016/j.prdoa.2020.100042 Text en © 2020 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Short Communication Xu, Yaqian Mirelman, Anat Saunders-Pullman, Rachel Mejia-Santana, Helen Caccappolo, Elise Raymond, Deborah Giladi, Nir Bressman, Susan Marder, Karen Alcalay, Roy N. Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients()() |
title | Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients()() |
title_full | Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients()() |
title_fullStr | Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients()() |
title_full_unstemmed | Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients()() |
title_short | Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients()() |
title_sort | differences in performance on english and hebrew versions of the moca in parkinson's patients()() |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174235/ https://www.ncbi.nlm.nih.gov/pubmed/34095813 http://dx.doi.org/10.1016/j.prdoa.2020.100042 |
work_keys_str_mv | AT xuyaqian differencesinperformanceonenglishandhebrewversionsofthemocainparkinsonspatients AT mirelmananat differencesinperformanceonenglishandhebrewversionsofthemocainparkinsonspatients AT saunderspullmanrachel differencesinperformanceonenglishandhebrewversionsofthemocainparkinsonspatients AT mejiasantanahelen differencesinperformanceonenglishandhebrewversionsofthemocainparkinsonspatients AT caccappoloelise differencesinperformanceonenglishandhebrewversionsofthemocainparkinsonspatients AT raymonddeborah differencesinperformanceonenglishandhebrewversionsofthemocainparkinsonspatients AT giladinir differencesinperformanceonenglishandhebrewversionsofthemocainparkinsonspatients AT bressmansusan differencesinperformanceonenglishandhebrewversionsofthemocainparkinsonspatients AT marderkaren differencesinperformanceonenglishandhebrewversionsofthemocainparkinsonspatients AT alcalayroyn differencesinperformanceonenglishandhebrewversionsofthemocainparkinsonspatients |